Form 4 for XLO Xilio Therapeutics, Inc.
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-02 · accession 0001062993-24-008004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-03 | 2024-04-02 | XLO | GILEAD SCIENCES, INC. | 10% | P - Purchase | $0.76 | +485.2K | 7.35M | +7% | +$368.8K |
| D | 2024-04-03 | 2024-04-02 | XLO | GILEAD SCIENCES, INC. | 10% | P - Purchase | $0.76 | +3.88M | 3.88M | New | +$2.95M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-02 | P | A | 485,250 | $0.76 | 7,345,473 | D | — | — | |
| 2 | Derivative | Prefunded Warrants (right to buy) | 2024-04-02 | P | A | 3,882,450 | $0.76 | 3,882,450 | D | $0.00 · — to — | 3,882,450 Common Stock | (F1) The Prefunded Warrants have no expiration date and are exercisable at any time on or after the date of issuance. A holder of Prefunded Warrants may not exercise the Prefunded Warrants if, after giving effect to such exercise, the holder and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the outstanding shares of Common Stock of the Issuer. |